187 related articles for article (PubMed ID: 7903262)
1. P-glycoprotein regulates chemosensitivity in early developmental stages of the mouse.
Elbling L; Berger W; Rehberger A; Waldhör T; Micksche M
FASEB J; 1993 Dec; 7(15):1499-506. PubMed ID: 7903262
[TBL] [Abstract][Full Text] [Related]
2. A novel bioassay for P-glycoprotein functionality using cytochalasin D.
Elbling L; Berger W; Weiss RM; Printz D; Fritsch G; Micksche M
Cytometry; 1998 Mar; 31(3):187-98. PubMed ID: 9515718
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.
Nielsen D; Skovsgaard T
Biochim Biophys Acta; 1992 Jul; 1139(3):169-83. PubMed ID: 1352705
[TBL] [Abstract][Full Text] [Related]
4. Effects of multidrug resistance-related ATP-binding-cassette transporter proteins on the cytoskeletal activity of cytochalasins.
Berger W; Micksche M; Elbling L
Exp Cell Res; 1997 Dec; 237(2):307-17. PubMed ID: 9434626
[TBL] [Abstract][Full Text] [Related]
5. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
[TBL] [Abstract][Full Text] [Related]
6. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines.
Park JG; Lee SK; Hong IG; Kim HS; Lim KH; Choe KJ; Kim WH; Kim YI; Tsuruo T; Gottesman MM
J Natl Cancer Inst; 1994 May; 86(9):700-5. PubMed ID: 7908989
[TBL] [Abstract][Full Text] [Related]
7. The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.
Spoelstra EC; Westerhoff HV; Pinedo HM; Dekker H; Lankelma J
Eur J Biochem; 1994 Apr; 221(1):363-73. PubMed ID: 7909520
[TBL] [Abstract][Full Text] [Related]
8. Effect of alpha-interferon on P-glycoprotein expression and function and on verapamil modulation of doxorubicin resistance.
Kang Y; Perry RR
Cancer Res; 1994 Jun; 54(11):2952-8. PubMed ID: 7910518
[TBL] [Abstract][Full Text] [Related]
9. Role of P-glycoprotein in dolastatin 10 resistance.
Toppmeyer DL; Slapak CA; Croop J; Kufe DW
Biochem Pharmacol; 1994 Aug; 48(3):609-12. PubMed ID: 7915113
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of daunorubicin transport in Ehrlich ascites tumor cells with different expression of P-glycoprotein.
Nielsen D; Maare C; Skovsgaard T
Biochem Pharmacol; 1994 Jun; 47(12):2125-35. PubMed ID: 7913318
[TBL] [Abstract][Full Text] [Related]
11. Modulation of mitomycin C-induced multidrug resistance in vitro.
Dorr RT; Liddil JD
Cancer Chemother Pharmacol; 1991; 27(4):290-4. PubMed ID: 1671830
[TBL] [Abstract][Full Text] [Related]
12. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
13. Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells.
Dong Z; Radinsky R; Fan D; Tsan R; Bucana CD; Wilmanns C; Fidler IJ
J Natl Cancer Inst; 1994 Jun; 86(12):913-20. PubMed ID: 7910854
[TBL] [Abstract][Full Text] [Related]
14. D-verapamil downmodulates P170-associated resistance to doxorubicin, daunorubicin and idarubicin.
Damiani D; Michieli M; Michelutti A; Melli C; Cerno M; Baccarani M
Anticancer Drugs; 1993 Apr; 4(2):173-80. PubMed ID: 8098233
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection.
Choi K; Frommel TO; Stern RK; Perez CF; Kriegler M; Tsuruo T; Roninson IB
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7386-90. PubMed ID: 1678523
[TBL] [Abstract][Full Text] [Related]
16. Constitutive expression of functional P-glycoprotein in rat hepatoma cells.
Fardel O; Loyer P; Lecureur V; Glaise D; Guillouzo A
Eur J Biochem; 1994 Jan; 219(1-2):521-8. PubMed ID: 7905826
[TBL] [Abstract][Full Text] [Related]
17. Regulation by dexamethasone of P-glycoprotein expression in cultured rat hepatocytes.
Fardel O; Lecureur V; Guillouzo A
FEBS Lett; 1993 Jul; 327(2):189-93. PubMed ID: 8101494
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the multidrug resistance gene product in adult rat hepatocytes during primary culture.
Fardel O; Ratanasavanh D; Loyer P; Ketterer B; Guillouzo A
Eur J Biochem; 1992 Apr; 205(2):847-52. PubMed ID: 1349283
[TBL] [Abstract][Full Text] [Related]
19. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
